| 摘要 |
Disclosed is the use of a compound of formula I, where the substituents and variables are as defined in the specification, to treat insulin resistance syndrome, diabetes including Type I Diabetes and Type II Diabetes, polycystic ovary syndrome, atherosclerosis, arteriosclerosis, obesity, hypertension, hyperlipidemia, fatty liver disease, nephropathy, neuropathy, retinopathy, foot ulceration or cataracts associated with diabetes hyperlipidemia, cachexia, or obesity.
|
